Moreover, previous studies have shown that IFN-γ is a key driver of PD-L1 expression and host tumor-infiltrating lymphocytes, which mediate PD-L1 expression through IFN-γ secretion in many cancer types and participate in the regulation of tumor immune escape [36–38]. The gene discussed is IFNG; the disease is neoplasm.